CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Guizhou Yibai Pharmaceutical Co., Ltd. Company Snapshot
Guizhou Yibai Pharmaceutical Co., Ltd. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Guizhou Yibai Pharmaceutical Co., Ltd. with three other companies in this sector in CHINA : Heilongjiang ZBD Pharmaceutical Co Ltd (2019 sales of 3.29 billion Chinese Renmimbi [US$464.86 million] of which 62% was Pharmaceutical Industry), Chengdu Kanghong Pharmaceutical Group Co Ltd (3.26 billion Chinese Renmimbi [US$459.98 million] of which 100% was Pharmaceutical Manufacturing), and Anhui Fengyuan Pharmaceutical (3.24 billion Chinese Renmimbi [US$457.28 million] of which 51% was Medicine Manufacturing).

Sales Analysis. During the year ended December of 2019, sales at Guizhou Yibai Pharmaceutical Co., Ltd. were 3.36 billion Chinese Renmimbi (US$474.64 million). This is a decrease of 13.4% versus 2018, when the company's sales were 3.88 billion Chinese Renmimbi. The sales level in 2019 was fairly close to the level five years ago: in 2014, Guizhou Yibai Pharmaceutical Co., Ltd. had sales of 3.16 billion Chinese Renmimbi. Contributing to the drop in overall sales was the 38.1% decline in Medical Service, from 879.77 million Chinese Renmimbi to 544.75 million Chinese Renmimbi. There were also decreases in sales in Medical Industry (down 6.3% to 2.80 billion Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Guizhou Yibai Pharmaceutical Co., Ltd.
  Stock Performance Chart for Guizhou Yibai Pharmaceutical Co., Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (6/24/2020): 6.62
(Figures in Chinese Renmimbi)
1 Week 5.4%   13 Weeks 11.6%  
4 Weeks 31.6%   52 Weeks 26.1%  
 
Guizhou Yibai Pharmaceutical Co., Ltd. Key Data:
  Ticker: 600594 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 3,361,025,745
(Year Ending Jan 2020).
Employees: 5,837
  Currency: Chinese Renmimbi Market Cap: 5,242,559,388
  Fiscal Yr Ends: December Shares Outstanding: 791,927,400
  Share Type: A Gu Closely Held Shares: 246,188,440
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.